Searched for
AUROBINDO PHARMA Q2 NET PROFIT
Ashok Leyland: A stronger balance sheet inside a business that will always remain cyclicalQuarterly numbers tell you what happened. But they do not always tell you why it happened. In commercial vehicles, demand can change becaus...- Ashok Leyland's best year in its history, and what the annual report says about holding on to itAshok Leyland sold more commercial vehicles in FY26 than in any year since it was founded, earned its highest-ever profit, and closed with ...
- Ashok Leyland just had a record June quarter. So why did the margin fall a full point?Ashok Leyland's June-quarter has an unusual contradiction. The company sold 48,763 commercial vehicles, its highest-ever first-quarter volu...
- RIL Q2 Results: Nuvama sees 17% EBITDA growth, led by O2C biz. Here’s what to expectReliance Industries is expected to report 17% year-on-year growth in Q2FY27 EBITDA to Rs 53,700 crore, led by stronger refining margins and...
- Cupid shares hit fresh 52-week high as firm raises FY27 revenue, profit guidance again; multibagger stock skyrockets 617% in a yearCupid shares hit a 52-week high after raising its FY27 guidance for the second time in two weeks, targeting Rs 800 crore revenue and Rs 250...
- Stocks in news: Infosys, HDFC Bank, Jio Financial, IRFC, NCC and Blue DartIndian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...
- Globalisation 2.0, can it be furrowed home?Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...
- Will RBI rate hikes intensify selloff in bank stocks? Analysts explain why fears may be overdoneBank shares have endured steep declines as investors brace for imminent interest rate hikes from the RBI. Some analysts suggest that the re...
- Q2 earnings: Can India Inc repeat Q1, or will Q3 erase the base-effect tailwind?India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...
- AI deflation, weak demand to keep large IT growth muted in Q2FY27; mid-tier to outperform: KotakIndia's large IT companies are anticipated to report subdued growth in Q2FY27 due to AI-led deflation and weak demand. Mid-tier firms are l...
- Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s whyLenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA mar...
- Americans are struggling to find affordable used cars: Here's what a $10,000-$15,000 budget gets you in 2026Used-car buyers are encountering obstacles as they search for older models that come with increased mileage and higher prices. The pool of ...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target priceGoldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eterna...
- Shein returns to profit in second quarter, but warns of uncertain second halfAn increase in total orders fulfilled supported a more than 20% sequential jump in Shein's second-quarter net revenue, although the Iran co...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Suzlon Energy shares fall 2% to near six-month low, down 15% in one monthSuzlon Energy shares slipped over 2% to a near six-month low, approaching their 52-week low amid higher trading volumes and broader market ...
- PC Jeweller shares rise 4% as firm becomes debt-free; stock rallies 89% in 6 monthsPC Jeweller has become debt-free after clearing dues to all 14 consortium banks ahead of schedule, strengthening its balance sheet. The sto...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
Load More
